← Open Payments lookup

DANIEL GARDNER: Open Payments

NPI 1275913279 · DAPHNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,472 in 144 payments from 23 companies in 2025. Trend: 2023 $2,260 · 2024 $2,692 · 2025 $3,472

Food & beverage: $3,387Education: $85
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP24$637
Regeneron Healthcare Solutions, Inc.16$425
Genentech USA, Inc.12$320
GENZYME CORPORATION12$268
Takeda Pharmaceuticals U.S.A., Inc.7$258
Novartis Pharmaceuticals Corporation11$231
Incyte Corporation6$150
GlaxoSmithKline, LLC.9$148
Verona Pharma, Inc.7$147
ARS Pharmaceuticals Operations, Inc.5$139

Products named: DUPIXENT, TEZSPIRE, XOLAIR, CUVITRU, OPZELURA, Ohtuvayre, NEFFY, Sunosi.

Industry payments across AL — which companies pay providers there.